ADM
28
3
NOV
52
-5
LB
30
4
KIM
72
2
CAG
24
-3
AZO
50
-5
TDC
67
-4
GME
66
-5
WM
74
-5
AON
54
2
CMA
61
-3
VNO
46
-13
ALLE
37
-4
MU
28
-3
HSY
31
-6
CSX
57
-4
GM
74
5
PAYX
48
-6
GT
56
-3
ZBH
65
3
ADM
28
3
NOV
52
-5
LB
30
4
KIM
72
2
CAG
24
-3
AZO
50
-5
TDC
67
-4
GME
66
-5
WM
74
-5
AON
54
2
CMA
61
-3
VNO
46
-13
ALLE
37
-4
MU
28
-3
HSY
31
-6
CSX
57
-4
GM
74
5
PAYX
48
-6
GT
56
-3
ZBH
65
3
Financhill
Back

Apellis Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
33

APLS
Apellis Pharmaceuticals

Last Price:
26.19
Seasonality Move:
20.78%
Buy
56

BMRN
Biomarin Pharmaceutical

Last Price:
61.92
Seasonality Move:
13.04%
Sell
33
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $26.27. The Score for APLS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $63.42. The Score for BMRN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $26.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $63.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 36.3 Sell
Chaikin Money Flow: -4148679 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.02 - 28.78) Sell
Bollinger Bands (100): (29.08 - 39.08) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.75 Sell
Relative Strength Index (14 RSI): 26.27 Sell
Chaikin Money Flow: -1448636 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.93 - 70.21) Sell
Bollinger Bands (100): (69.5 - 87.66) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.63 Sell
20-day SMA: 27.95 Sell
50-day SMA: 30.19 Sell
200-day SMA: 43.29 Sell
8-day EMA: 28.09 Sell
20-day EMA: 28.31 Sell
50-day EMA: 30.23 Sell
200-day EMA: 40.03 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.04 Sell
20-day SMA: 67.52 Sell
50-day SMA: 70.73 Sell
200-day SMA: 81.7 Sell
8-day EMA: 65.78 Sell
20-day EMA: 67.26 Sell
50-day EMA: 71.26 Sell
200-day EMA: 80.23 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):